While biopharmaceutical and med-tech executives were wheeling, dealing and dining beneath the logo of a 24-karat gold pill at the 37th Annual J.P. Morgan (JPM) Healthcare Conference, patients continued to cut back on their life-saving drugs because they couldn't afford their medications.